Curis, Inc. to Present at Lazard Capital Markets 5th Annual Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at Lazard Capital Markets 5th Annual Healthcare Conference, at 1:30 p.m. EST on November 19, 2008, at the St. Regis Hotel in New York, New York.

Back to news